tiprankstipranks
Cipher Pharmaceuticals (CPHRF)
OTHER OTC:CPHRF
US Market
CPHRF
Cipher Pharmaceuticals
RESEARCH TOOLSreports

Cipher Pharmaceuticals (CPHRF) Ratios

20 Followers

Cipher Pharmaceuticals Ratios

CPHRF's free cash flow for Q1 2026 was $0.68. For the 2026 fiscal year, CPHRF's free cash flow was decreased by $ and operating cash flow was $0.45. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 1.25 1.12 1.94 9.19 4.07
Quick Ratio
 0.85 0.79 1.64 8.62 3.84
Cash Ratio
 0.31 0.30 0.90 7.58 3.08
Solvency Ratio
 1.77 0.92 0.26 3.92 2.85
Operating Cash Flow Ratio
 1.48 1.21 0.98 3.05 1.13
Short-Term Operating Cash Flow Coverage
 114.35 104.85 0.00 0.00 0.00
Net Current Asset Value
$ 4.97M$ -2.21M$ -21.68M$ 42.76M$ 28.46M
Leverage Ratios
Debt-to-Assets Ratio
 <0.01 0.04 0.25 <0.01 <0.01
Debt-to-Equity Ratio
 <0.01 0.04 0.40 <0.01 <0.01
Debt-to-Capital Ratio
 <0.01 0.04 0.28 <0.01 <0.01
Long-Term Debt-to-Capital Ratio
 0.00 0.04 0.28 0.00 0.00
Financial Leverage Ratio
 1.15 1.24 1.59 1.07 1.15
Debt Service Coverage Ratio
 46.65 18.42 0.00 0.00 0.00
Interest Coverage Ratio
 39.01 14.17 0.00 0.00 0.00
Debt to Market Cap
 <0.01 0.02 0.16 0.00 0.00
Interest Debt Per Share
 0.04 0.26 1.64 0.01 0.02
Net Debt to EBITDA
 -0.24 -0.12 1.92 -3.42 -2.36
Profitability Margins
Gross Profit Margin
74.53%65.79%72.24%80.77%80.69%
EBIT Margin
38.76%32.73%23.52%48.68%53.45%
EBITDA Margin
49.33%32.73%35.56%54.48%58.23%
Operating Profit Margin
38.76%32.73%23.52%54.48%58.23%
Pretax Profit Margin
39.70%34.02%8.86%59.92%55.52%
Net Profit Margin
60.82%54.17%34.60%96.32%128.83%
Continuous Operations Profit Margin
60.82%54.17%34.60%96.32%128.83%
Net Income Per EBT
153.21%159.23%390.69%160.74%232.04%
EBT Per EBIT
102.43%103.94%37.65%109.99%95.35%
Return on Assets (ROA)
20.19%17.80%7.10%23.69%36.10%
Return on Equity (ROE)
25.69%22.07%11.28%25.31%41.57%
Return on Capital Employed (ROCE)
14.84%12.80%5.50%14.27%18.69%
Return on Invested Capital (ROIC)
14.81%12.78%5.49%14.26%18.66%
Return on Tangible Assets
47.62%41.55%17.41%29.73%48.15%
Earnings Yield
10.13%9.95%4.69%19.15%37.41%
Efficiency Ratios
Receivables Turnover
 5.22 4.59 2.41 4.16 3.04
Payables Turnover
 1.99 2.75 1.58 0.88 0.97
Inventory Turnover
 1.58 2.15 1.60 1.36 1.86
Fixed Asset Turnover
 106.45 90.38 49.06 52.64 42.98
Asset Turnover
 0.33 0.33 0.21 0.25 0.28
Working Capital Turnover Ratio
 12.52 4.75 1.08 0.59 0.90
Cash Conversion Cycle
 117.75 116.85 148.44 -60.88 -58.67
Days of Sales Outstanding
 69.95 79.53 151.63 87.76 120.08
Days of Inventory Outstanding
 230.87 169.90 228.30 267.49 196.76
Days of Payables Outstanding
 183.07 132.58 231.50 416.13 375.51
Operating Cycle
 300.82 249.43 379.93 355.25 316.85
Cash Flow Ratios
Operating Cash Flow Per Share
 1.19 1.19 0.79 0.63 0.42
Free Cash Flow Per Share
 1.19 1.19 0.79 0.63 0.42
CapEx Per Share
 <0.01 <0.01 <0.01 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
 1.00 1.00 1.00 1.00 0.99
Dividend Paid and CapEx Coverage Ratio
 280.17 1.06K 444.23 111.10 130.56
Capital Expenditure Coverage Ratio
 280.17 1.06K 444.23 111.10 130.56
Operating Cash Flow Coverage Ratio
 70.26 5.50 0.48 45.32 24.71
Operating Cash Flow to Sales Ratio
 0.59 0.59 0.59 0.76 0.51
Free Cash Flow Yield
9.76%10.81%7.93%15.01%14.74%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 9.86 10.05 21.31 5.22 2.67
Price-to-Sales (P/S) Ratio
 6.02 5.44 7.37 5.03 3.44
Price-to-Book (P/B) Ratio
 2.30 2.22 2.40 1.32 1.11
Price-to-Free Cash Flow (P/FCF) Ratio
 10.22 9.25 12.61 6.66 6.78
Price-to-Operating Cash Flow Ratio
 10.14 9.24 12.59 6.65 6.73
Price-to-Earnings Growth (PEG) Ratio
 0.04 0.08 -0.52 -0.21 0.01
Price-to-Fair Value
 2.30 2.22 2.40 1.32 1.11
Enterprise Value Multiple
 11.97 16.52 22.65 5.81 3.55
Enterprise Value
 301.19M 277.49M 268.74M 66.94M 42.79M
EV to EBITDA
 11.99 16.52 22.65 5.81 3.55
EV to Sales
 5.91 5.41 8.05 3.16 2.07
EV to Free Cash Flow
 10.04 9.18 13.78 4.19 4.08
EV to Operating Cash Flow
 10.01 9.17 13.75 4.18 4.05
Tangible Book Value Per Share
 1.76 1.44 0.25 2.47 1.82
Shareholders’ Equity Per Share
 5.25 4.94 4.14 3.16 2.55
Tax and Other Ratios
Effective Tax Rate
 -0.53 -0.59 -2.91 -0.61 -1.32
Revenue Per Share
 2.01 2.01 1.35 0.83 0.82
Net Income Per Share
 1.22 1.09 0.47 0.80 1.06
Tax Burden
 1.53 1.59 3.91 1.61 2.32
Interest Burden
 1.02 1.04 0.38 1.23 1.04
Research & Development to Revenue
 0.00 0.00 0.00 <0.01 <0.01
SG&A to Revenue
 0.29 0.33 0.37 0.22 0.19
Stock-Based Compensation to Revenue
 0.02 0.00 0.03 0.06 0.02
Income Quality
 0.97 1.09 1.69 0.78 0.40
Currency in USD